Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in Qatar.
Campus
Campus

The SoliRam observational study

Prof. Abdulrahman A. Alshaikh, Professor Physician & Endocrinologist at KAU & DSFH, Chairman of Saudi Scientific Diabetes Society, Saudi Arabia, presents iGlarLixi safety and effectiveness in adults with T2D who fast during Ramadan in Gulf region (SoliRam study sub-analysis).

Related articles
Glargine 300 use in people with type 2 diabetes who fast during Ramadan
  • Diabetes

Glargine 300 use in people with type 2 diabetes who fast during Ramadan

Watch Professor Mohamed Hassanein, consultant endocrinologist in Dubai Hospital, Dubai Health Authority and the chair of Diabetes and Ramadan International Alliance shedding the light on what are the unmet needs amongst Muslims with Type 2 diabetes when fast during Ramadan.

Read article
Challenges associated with commonly-used insulin advancement options
  • Diabetes

Challenges associated with commonly-used insulin advancement options

Read article
Treatment simplification of complex insulin regimens in T2D
  • Diabetes

Treatment simplification of complex insulin regimens in T2D

Read article
MAT-BH-2300251/V1/March2023